Premenstrual Syndrome Treatment Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 18
SKU : PH2390
excelpdfpowerpoint
180 pages
Report Summary
Table of Contents
List of Tables & Figures
loading
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Proceed to Buy
Request new version
FAQ’s
How big is the Premenstrual Syndrome Treatment Market ?
Premenstrual Syndrome Treatment Market size was valued USD 1,367 million in 2022 and is estimated to reach USD 1,829 million by 2031
Who are the key players in Premenstrual Syndrome Treatment Market?
Key players are Bayer AG, Eli Lilly And Company, GlaxoSmithKline Plc., H. Lundbeck A/S, Pfizer Inc., Asarina Pharma AB, Chattem, Inc. (Sanofi), Dekk-Tec, Pherin Pharmaceuticals and Novartis International AG.
Related Reports
pharmaceuticals

Chronic Disease Management Market Size, Share, Industry, Forecast and Outlook (2023-2030)

Published: 2023 September 26
Starting from

$4350

pharmaceuticals

Scabies Treatment Market Size, Share, Industry, Forecast and Outlook (2023-2030)

Published: 2023 September 26
Starting from

$4350

pharmaceuticals

Geographic Atrophy Market Size, Share, Industry, Forecast and Demand (2023-2030)

Published: 2023 September 26
Starting from

$4350

pharmaceuticals

Bacterial (Pyogenic) Meningitis Market Size, Share, Industry, Forecast and Outlook (2023-2030)

Published: 2023 September 26
Starting from

$4350

pharmaceuticals

Liposarcoma Market Size, Share, Industry, Forecast and Outlook (2023-2030)

Published: 2023 September 26
Starting from

$4350

pharmaceuticals

Postpartum Depression Market Size, Share, Industry, Forecast and Outlook (2023-2030)

Published: 2023 September 26
Starting from

$4350